Hani Choudhry
Affiliations: | 2010-2014 | University of Oxford, Oxford, United Kingdom |
Google:
"Hani Choudhry"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dalhat MH, Choudhry H, Khan MI. (2023) NAT10, an RNA Cytidine Acetyltransferase, Regulates Ferroptosis in Cancer Cells. Antioxidants (Basel, Switzerland). 12 |
| Lafleur VN, Halim S, Choudhry H, et al. (2023) Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life Science Alliance. 6 |
| Lombardi O, Li R, Halim S, et al. (2022) Pan-cancer analysis of tissue and single-cell HIF-pathway activation using a conserved gene signature. Cell Reports. 41: 111652 |
| Dalhat MH, Mohammed MRS, Alkhatabi HA, et al. (2022) NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells. Clinical and Translational Medicine. 12: e1045 |
| Khan MI, Alsayed RKME, Choudhry H, et al. (2022) Exosome-Mediated Response to Cancer Therapy: Modulation of Epigenetic Machinery. International Journal of Molecular Sciences. 23 |
| Shait Mohammed MR, Zamzami M, Choudhry H, et al. (2022) The Histone H3K27me3 Demethylases KDM6A/B Resist Anoikis and Transcriptionally Regulate Stemness-Related Genes. Frontiers in Cell and Developmental Biology. 10: 780176 |
| Choudhry H. (2021) UCA1 Overexpression Promotes Hypoxic Breast Cancer Cell Proliferation and Inhibits Apoptosis via HIF-1 Activation. Journal of Oncology. 2021: 5512156 |
| Omran Z, H Dalhat M, Abdullah O, et al. (2021) Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors. Cancers. 13 |
| Shait Mohammed MR, Alghamdi RA, Alzahrani AM, et al. (2021) Compound C, a Broad Kinase Inhibitor Alters Metabolic Fingerprinting of Extra Cellular Matrix Detached Cancer Cells. Frontiers in Oncology. 11: 612778 |
| Choudhry H. (2021) The Microbiome and Its Implications in Cancer Immunotherapy. Molecules (Basel, Switzerland). 26 |